Management of antipsychotic-induced hyperprolactinemia

INTRODUCTION: Antipsychotics represent a large portion of the psychotropics that may induce hyperprolactinemia. Clinical psychiatric pharmacists must be adept in stratifying the relative risk of hyperprolactinemia among psychotropics, identifying patient risk factors, recognizing differential diagno...

Descripción completa

Detalles Bibliográficos
Autores principales: Tewksbury, Ashley, Olander, Amy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: College of Psychiatric & Neurologic Pharmacists 2016
Materias:
Physical Side Effects of Psychoactive Meds
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007722/
https://www.ncbi.nlm.nih.gov/pubmed/29955468
http://dx.doi.org/10.9740/mhc.2016.07.185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007722/
https://www.ncbi.nlm.nih.gov/pubmed/29955468
http://dx.doi.org/10.9740/mhc.2016.07.185

Ejemplares similares